#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Proteus syndrome Factor IX deficiency Tuberous sclerosis complex Primitive neuroectodermal tumour Cardiomyopathy Pancreatic carcinoma Acute myeloid leukaemia recurrent Ornithine transcarbamoylase deficiency Prostate cancer Pyruvate kinase deficiency anaemia Acromegaly Acute myeloid leukaemia (in remission) Langerhans cell sarcoma Ocular lymphoma Diffuse large B-cell lymphoma refractory More trials…

    Learn about Rare Diseases

    Atypical teratoid/rhabdoid tumour of CNS Bronchopulmonary dysplasia Mucopolysaccharidosis III – Life with Disease Langerhans’ cell histiocytosis – Life with Disease Erdheim-Chester disease – Trials in Disease Medulloblastoma – Basic Information Undifferentiated sarcoma – Treatment Niemann-Pick disease – Life with Disease Urea cycle disorder – Treatment Synovial sarcoma metastatic – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Warfarin Sodium FRUQUINTINIB Garetosmab Lovo-A 99MTC-EUK-(SO3)CY5-MAS3 Mk-0616 Kk8123 Indacaterol Acetate Pritelivir Ecoo18A Human Vaccinia Immunoglobulin Dobutamine Hydrochloride Betula Alba Pollen Extract SODIUM SULFIDE NONAHYDRATE Iptacopan Rosnilimab Tianeptine Pozelimab Temozolomide Ds-3939A More therapies…

    Learn about Your Condition

    Bile duct adenocarcinoma Malformation venous Carcinoid syndrome Vulvovaginal candidiasis Lung adenocarcinoma stage IV Developmental hip dysplasia Tricuspid valve disease Aortic disorder Ulcerative keratitis Hypertension Red blood cell abnormality Tissue anoxia Hepato-lenticular degeneration Stomatitis Hand fracture More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of 18F-FAPI-74 PET/CT Imaging to Detect Cancer Spread in Patients with Non-Small Cell Lung Cancer

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • [Al[18F]F]Fapi-74
    Finland

  • A Study of Semaglutide for Diabetic Patients with Heart Attack or Unstable Angina to Measure Changes in Coronary Artery Plaque Using Imaging

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute coronary syndrome
    • Diabetes mellitus
    Investigated Drugs:
    • Semaglutide
    Italy

  • Comparing 7-Day and 4-Week Esomeprazole Treatment in Patients with Unexplained Dyspepsia

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Dyspepsia
    Investigated Drugs:
    • MAGNESIUM CARBONATE HEAVY
    • Calcium Carbonate
    • Esomeprazole
    Iceland

  • A Study of Semaglutide in Overweight or Obese Patients with Atrial Fibrillation Scheduled for Catheter Ablation to Improve Treatment Outcomes

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Semaglutide
    Sweden

  • A Study Testing Propranolol for Patients with Traumatic Brain Injury Who Need Intensive Care Unit Treatment

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Craniocerebral injury
    Investigated Drugs:
    • Propranolol Hydrochloride
    Spain

  • Testing the safety and effectiveness of stem cells from fat tissue in children with autism spectrum disorder and digestive problems

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Autism spectrum disorder
    Denmark
Previous Page
1 … 748 749 750 751 752 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!